We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$90.5B
AUM Growth
+$6.75B
Cap. Flow
-$1.78B
Cap. Flow %
-1.96%
Top 10 Hldgs %
8.27%
Holding
5,609
New
475
Increased
1,793
Reduced
1,541
Closed
783

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$826M
2
MSFT icon
Microsoft
MSFT
+$549M
3
PDD icon
Pinduoduo
PDD
+$305M
4
INTC icon
Intel
INTC
+$274M
5
AAPL icon
Apple
AAPL
+$266M

Sector Composition

Rank Sector Weight
1 Technology 13.35%
2 Healthcare 8.99%
3 Financials 7.94%
4 Consumer Discretionary 7.49%
5 Industrials 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCAGR
4401
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$16.4K ﹤0.01%
73,333
VLD.WS
4402
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$16.4K ﹤0.01%
79,978
-5,022
-6% -$2.37K
JUN.WS
4403
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$16.3K ﹤0.01%
100,000
FFAI
4404
Faraday Future Intelligent Electric
FFAI
$11.6M
0
EUDAW icon
4405
EUDA Health Holdings Warrant
EUDAW
$268K
$16K ﹤0.01%
200,000
ASBPW
4406
Aspire Biopharma Warrant
ASBPW
$314K
$16K ﹤0.01%
199,999
BRD.WS
4407
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$16K ﹤0.01%
199,999
JMACW
4408
DELISTED
Maxpro Capital Acquisition Corp. Warrants
JMACW
$15.9K ﹤0.01%
318,530
UTAAW
4409
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$15.6K ﹤0.01%
149,999
GGROW
4410
Gogoro Inc Warrant
GGROW
$133K
$15.4K ﹤0.01%
44,015
GCTS.WS
4411
GCT Semiconductor Holding Warrants
GCTS.WS
$15.3M
$15.3K ﹤0.01%
225,000
FRBNW
4412
DELISTED
Forbion European Acquisition Corp. Warrants
FRBNW
$15.2K ﹤0.01%
104,722
CCVI.WS
4413
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$15.1K ﹤0.01%
252,481
SAMAW
4414
DELISTED
Schultze Special Purpose Acquisition Corp. II Warrant
SAMAW
$14.9K ﹤0.01%
742,500
BYNOW
4415
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$14.8K ﹤0.01%
742,500
DMAQR
4416
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
$14.8K ﹤0.01%
296,800
RCFA.WS
4417
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$14.8K ﹤0.01%
199,999
MIMO.WS
4418
DELISTED
Airspan Networks Holdings Inc Warrants
MIMO.WS
$14.7K ﹤0.01%
473,686
ONMDW icon
4419
OneMedNet Corp Warrant
ONMDW
$912K
$14.6K ﹤0.01%
420,000
CLINR
4420
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$14.4K ﹤0.01%
125,000
DNA.WS
4421
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$14.2K ﹤0.01%
71,236
MAQCW
4422
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
$14.2K ﹤0.01%
395,000
AONCW
4423
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$14.2K ﹤0.01%
220,646
GRMLW
4424
Greenland Mines Ltd Warrant
GRMLW
$14.1K ﹤0.01%
300,000
SLAMW
4425
DELISTED
Slam Corp. warrant
SLAMW
$14.1K ﹤0.01%
159,816

Similar funds

David Shaw's Q4 2022 Portfolio in Review

As of Q4 2022, David Shaw held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

David Shaw's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • David Shaw's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
  • David Shaw added most to Tesla in Q4 2022, an estimated $826M increase.
  • David Shaw's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
  • David Shaw fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
  • David Shaw's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
  • David Shaw opened 475 new positions and closed 783 in Q4 2022.
  • David Shaw's portfolio value rose 8.1% quarter-over-quarter to $90.5B.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.